Leslie Sloan
Overview
Leslie Sloan received an average of $1M in total compensation, including $393K in salary, at Aeglea BioTherapeutics from 2019 to 2022.
Source: SEC filings on October 26, 2023, April 21, 2022, and April 23, 2020.
Related executives
We found nine more executives who work or worked at Aeglea BioTherapeutics.
Anthony Quinn
Aeglea BioTherapeutics
Chief Executive Officer
Jeffrey Goldberg
Aeglea BioTherapeutics
Chief Executive Officer
Jonathan Alspaugh
Aeglea BioTherapeutics
Chief Financial Officer
Jim Kastenmayer
Aeglea BioTherapeutics
Chief Executive Officer
Michael Hanely
Aeglea BioTherapeutics
Chief Operating Officer
Charles York
Aeglea BioTherapeutics
Chief Financial Officer
James Wooldridge
Aeglea BioTherapeutics
Chief Medical Officer
David Lowe
Aeglea BioTherapeutics